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Abstract
The optimal medium for cardiac differentiation of adult primitive cells remains to be established. 
We quantitatively compared the efficacy of IGF-1, dynorphin B, insulin, oxytocin, bFGF, and 
TGF-β1 in inducing cardiomyogenic differentiation. Adult mouse skeletal muscle-derived Sca1+/
CD45-/c-kit-/Thy-1+ (SM+) and Sca1-/CD45-/c-kit-/Thy-1+ (SM−) cells were cultured in basic 
medium (BM; DMEM, FBS, IGF-1, dynorphin B) alone and BM supplemented with insulin, 
oxytocin, bFGF, or TGF-β1. Cardiac differentiation was evaluated by the expression of cardiac-
specific markers at the mRNA (qRT-PCR) and protein (immunocytochemistry) levels. BM+TGF-
β1 upregulated mRNA expression of Nkx2.5 and GATA-4 after 4 days and Myl2 after 9 days. After 
30 days, BM+TGF-β1 induced the greatest extent of cardiac differentiation (by morphology and 
expression of cardiac markers) in SM− cells. We conclude that TGF-β1 enhances cardiomyogenic 
differentiation in skeletal muscle-derived adult primitive cells. This strategy may be utilized to 
induce cardiac differentiation as well as to examine the cardiomyogenic potential of adult tissue-
derived stem/progenitor cells.
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Introduction
Results from numerous studies in animals indicate that therapy with adult stem/progenitor 
cells can ameliorate left ventricular (LV) remodeling and improve LV function after 
myocardial infarction [9, 18, 25]. Based on this phenomenological evidence, several clinical 
trials of cell therapy for cardiac repair have been completed or are in progress [1]. Although 
controversial, differentiation of transplanted cells into cells of cardiac lineages has been 
proposed as one of the mechanisms underlying these beneficial effects. Therefore, it is 
crucial to determine the cardiomyogenic potential of transplanted cells in vitro prior to 
transplantation in vivo. In this regard, it is important to formulate culture conditions that can 
predictably induce cardiomyocytic differentiation in candidate cells for cardiac repair in 
vivo. However, the impact of different growth factors/cytokines on the cardiomyogenic 
differentiation of adult stem/progenitors in vitro has not been systematically investigated.
We have previously reported that specific subsets of adult skeletal muscle-derived primitive 
cells can undergo cardiomyocytic differentiation in vitro [35]. In this study, we 
quantitatively examined the ability of six specific growth factors/cytokines in five 
combinations to induce cardiomyocytic differentiation in two subsets (Sca-1+/CD45-/c-kit-/
Thy-1+ [SM+] cells and Sca-1-/CD45-/c-kit-/Thy-1+ [SM−] cells) of skeletal muscle-
derived adult primitive cells in vitro. These factors (insulin-like growth factor [IGF]-1 [5], 
dynorphin B [32], insulin [29], oxytocin [22], basic fibroblast growth factor [bFGF] [28], 
and transforming growth [TGF]-β1 [6, 21] were selected because of their known 
involvement in cardiac development and/ or their ability to induce cardiac differentiation in 
Abdel-Latif et al. Page 2
Basic Res Cardiol. Author manuscript; available in PMC 2014 December 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
various stem cell lines. To our knowledge, this is the first systematic comparison of the 
ability of different growth factors and cytokines to induce cardiomyocytic differentiation in 
adult primitive cells in vitro in a controlled setting.
Materials and methods
The investigation conforms to the principles of laboratory animal care according to the 
Guide for the Care and Use of Laboratory Animals (Department of Health and Human 
Services, NIH Publication No. 86-23, revised 1996).
Animals
Adult C57BL/6 mice (age 6–10 weeks, body wt 20– 25 g) were used. Mice were bred and 
maintained at Indiana University according to protocols approved by the laboratory animal 
research facility (LARC) of the Indiana University School of Medicine. Each experimental 
group of donor C57BL/6 mice was obtained from the same litter.
Isolation of skeletal muscle-derived primitive cells
Cells were isolated according to previously published methods [35]. Briefly, following 
euthanasia, the hind limbs were removed and placed in Dulbecco’s Modified Eagle Medium 
(DMEM, Invitrogen). Adipose tissue and large vasculature were removed carefully with fine 
forceps and discarded. Skeletal muscle (sartorius, quadriceps, adductors, soleus, and 
gastrocnemius muscles) was carefully dissected, excised from tendons, and placed in 15 ml 
of fresh medium. Muscle tissue was triturated by repeated gentle pipetting and centrifuged at 
500 rpm for 10 min. The pelleted muscle tissue was digested in collagenase I (220 U/ml, 
Worthington Biochemical) and Dispase (33 U/ml, BD Biosciences) in 50 ml of DMEM for 
45 min at 37°C with gentle agitation [35]. Cells were then filtered through a 40-µm cell 
strainer into a sterile 50-ml conical tube. Viability was assessed by Trypan blue (Sigma) 
staining. Approximately 4 × 106 cells were obtained from each donor mouse.
Flow cytometric cell sorting
Freshly isolated cells were pelleted in PBS containing 1% FBS (HyClone), and FITC-
conjugated monoclonal antimouse Sca-1 (E13–161.7, BD Pharmingen), allophycocyanin 
(APC)-conjugated monoclonal antimouse CD45 and c-kit (30-F11 and 2B8, respectively, 
BD Pharmingen), and biotin-conjugated antimouse Thy-1.2 (53-2.1, BD Pharmingen) 
primary antibodies were added simultaneously. PE-conjugated streptavidin (Caltag 
Laboratories) was added subsequently. All staining was performed at 4°C for 20 min, and 
cells were washed with PBS supplemented with 1% FBS after staining. Flow cytometric cell 
sorting was performed using a MoFlo (Dako) and a FACS Vantage SE [35]. The sorting 
strategy is summarized in Fig. 1. Sorted cells were collected into tubes containing 2 ml 
DMEM with 10% FBS. Isolated cells were reanalyzed immediately after sorting to 
determine purity of sorting. The viability of sorted cells always exceeded 90%.
Cell culture
Freshly isolated SM+ and SM− cells were seeded at 5,000 cells/plate in gelatin-coated 22-
mm diameter plates. The basic medium (BM) consisted of DMEM supplemented with 10% 
Abdel-Latif et al. Page 3
Basic Res Cardiol. Author manuscript; available in PMC 2014 December 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FBS, IGF-1 (25 nM [2]; R&D Research), and dynorphin B (1 µM [32]; NeoMPS). IGF-1 
and dynorphin B, both of which have been shown to induce cardiac differentiation [2, 32], 
were added to the BM to synergistically augment the overall cardiomyogenic effects of these 
media. To determine the impact of specific supplements on cardiomyogenic differentiation, 
cells were cultured in BM alone and BM supplemented with insulin (10 µg/ ml [3]; Sigma), 
oxytocin (0.1 µM [22]; Becham California), bFGF (20 ng/ml [23, 30]; R&D Research), or 
TGF-β1 (2.5 ng/ml [6]; R&D Research). These concentrations were based on our careful 
review of the literature. We specifically avoided using a higher dose of TGF-β1 to obviate 
the induction of osteoblastic features [14]. Half of the medium was changed twice a week 
and cells were allowed to differentiate for 30 days.
Phenotypic analysis
Cells in each of 10 groups were evaluated on a daily basis under light microscopy and 
images were acquired using a digital camera (MRC5, Carl Zeiss, Inc., Thornwood, NY) and 
the Axiovision software (Carl Zeiss) to document changes in cellular morphology.
Assessment of mRNA expression by real-time qRT-PCR
For the analysis of mRNA expression of markers of cardiac differentiation (Nkx2.5, 
GATA-4, and Myl2), total mRNA was isolated from freshly isolated cells SM+ and SM− 
cells and after 4 and 9 days of culture (RNeasy, Qiagen), and reverse-transcribed (TaqMan, 
Applied Biosystems). Quantitative assessment of mRNA expression of all of the genes of 
interest and β2-microglobulin was performed by real-time qRT-PCR using an ABI PRISM® 
7000 System [35].
All of the primer sequences are provided in supplemental Table 1. Primers were designed 
with the Primer Express software. A 25-µl reaction mixture containing 12.5 µl of SYBR 
Green PCR Master Mix and 10 ng of forward and reverse primers was used. The threshold 
cycle (Ct), i.e., the cycle number at which the amount of amplified gene of interest reached a 
fixed threshold, was subsequently determined. Relative quantitation of mRNA expression 
was calculated with the comparative Ct method. The relative quantitative value of target, 
normalized to an endogenous control β2-microglobulin gene and relative to a calibrator, was 
expressed as 2−ΔΔCt (−fold difference), where ΔCt = (Ct of target genes [Nkx2.5, GATA-4, 
and Myl2]) – (Ct of endogenous control gene [β2-microglobulin]), and ΔΔCt = (ΔCt of 
samples for target gene) – (ΔCt of calibrator for the target gene). To avoid the possibility of 
amplifying contaminating DNA (1) all of the primers for real-time RT-PCR were designed 
to contain an intron sequence for specific cDNA amplification; (2) reactions were performed 
with appropriate negative controls (template-free controls); (3) a uniform amplification of 
the products was rechecked by analyzing the melting curves of the amplified products 
(dissociation graphs); and (4) the melting temperature (Tm) was 57–60°C with the probe Tm 
at least 10°C higher than the primer Tm [35]. Three independent experiments were 
performed for each set of genes.
Immunocytochemistry
The expression of cardiac-specific transcription factors (cTFs) and structural proteins (cSPs) 
was examined by immunocytochemical staining after 30 days of differentiation [35]. 
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Briefly, cells were fixed (4% paraformaldehyde), permeabilized (0.2% Triton X-100), 
blocked (10% donkey serum) and incubated with primary antibodies against Nkx2.5 (Santa 
Cruz), GATA-4 (Santa Cruz), cardiac myosin heavy chain (cMyHC, Novus Biologicals), α-
sarcomeric actin (Sigma), and a panel of primary antibodies against specific markers of 
noncardiac lineages (as described below) at a concentration of 1:100–1:200 for 16 h at 4°C. 
Following washing with PBS, appropriate fluorochrome-conjugated secondary antibodies 
(Jackson Immunoresearch) were added at a concentration of 1:100. Following staining with 
DAPI, cells were washed with PBS and a coverslip was applied for microscopic 
examination. Appropriate negative and specific positive controls were employed for each 
antigen to ensure the specificity of staining.
Quantitative assessment of cardiomyocytic differentiation
All images were acquired using a LSM 510 (Zeiss) confocal microscope. For quantitative 
assessment of the expression of cardiac-specific antigens, 500 cells/plate on average were 
systematically evaluated in multiple fields from all four quarters of the plate [35]. As 
previously reported [12, 33, 35], cardiac-specific transcription factors (Nkx2.5 [12, 35] and 
GATA-4 [33, 35]) were noted both in cytoplasm and in the nucleus. Cells with nuclear 
staining with or without cytoplasmic staining were counted as positives. For the purpose of 
exclusion, we also stained cells for markers specific for several noncardiac lineages (skeletal 
muscle [myogenin and Myf5]; neuron [nestin and GFAP]; fibroblast [PDGFR-α and -β]; 
chondrocyte [collagens I and II]; epithelial cell [cytokeratin 17]; macrophage [CD68]; and 
others) [35]. This rigorous approach enabled us to specifically identify cells with a 
cardiomyocytic phenotype. Cells that were positive for cardiac-specific markers and 
negative for noncardiac lineage markers were counted as positive, and the total number of 
cells in each field was calculated based on nuclear staining with DAPI. The percentage of 
cells differentiating into cardiomyocytes was calculated as the number of positive cells 
divided by the total number of nuclei in the field [35]. These experiments were performed in 
triplicate.
Statistical analysis
Data are mean ± SEM. The percentage of cells with a cardiac phenotype and quantitative 
mRNA data (-fold changes in mRNA levels) for cardiac-specific markers was analyzed with 
one-way or two-way (time and group) ANOVA. If the ANOVA showed an overall 
difference, post hoc contrasts were performed with Student’s t tests for unpaired data, and 
the resulting probability values were adjusted according to the Bonferroni correction 
(SPSS). A P < 0.05 was considered statistically significant.
Results
Isolated skeletal muscle-derived primitive cells
Skeletal muscle-derived primitive cells were isolated by FACS. Based on the expression of 
Sca-1, CD45, c-kit, and Thy-1, cells were sorted into Sca-1+/CD45-/ c-kit-/Thy-1+ (SM+) 
and Sca-1-/CD45-/c-kit-/Thy-1 + (SM−) populations according to the protocol summarized 
in Fig. 1.
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Impact of media composition on cell morphology during culture
Within the first 48 h after plating, both SM+ and SM− cells adhered to the gelatin-coated 
surface. During culture, SM+ cells cultured in all five different media exhibited greater 
morphological heterogeneity compared with SM− cells (Fig. 2a – e). During the 2nd–4th 
weeks, SM+ cells cultured in BM alone gradually differentiated into a combination of large 
flat cells with epithelial morphology and positive immunostaining for cytokeratin 17 (Fig. 
2f), isolated spindle-shaped cells, oval cells with endothelial morphology, and scattered 
cellular aggregates with an adipocytic phenotype (Fig. 2a). Addition of insulin (Fig. 2b) or 
oxytocin (Fig. 2c) to the BM resulted in markedly greater differentiation into adipocytes. 
Although BM+bFGF (Fig. 2d) and BM+TGF-β1 (Fig. 2e) induced differentiation into varied 
phenotypes, the frequency of spindle-shaped cells was less compared with SM− cells in 
respective media. In addition, SM+ cells cultured in BM+bFGF (Fig. 2d) and BM+TGF−β1 
(Fig. 2e) exhibited greater predisposition to differentiate into myotubes (Fig. 2g – j). 
Overall, SM+ cells exhibited greater propensity to differentiate into an adipose phenotype in 
all media.
Compared with SM+ cells, SM− cells cultured in all five media combinations exhibited 
greater morphological homogeneity (Fig. 3a – e). SM− cells cultured in BM alone 
differentiated into cells with epithelial and endothelial phenotypes with isolated spindle-
shaped cells (Fig. 3a). SM− cells in BM+insulin (Fig. 3b) and BM+oxytocin (Fig. 3c) 
differentiated into similar combinatorial phenotypes with predominant epithelial cells. In 
contrast, a greater fraction of SM− cells cultured in BM+bFGF (Fig. 3d) and BM+TGF–β1 
(Fig. 3e) showed predominantly spindle-shaped morphology. However, a fraction of these 
SM− cells cultured in BM+bFGF gradually acquired the phenotype characteristic of 
myotubes, while the mononucleate spindle-shaped SM− cells in BM+TGF–β1 
predominantly remained isolated with formation of occasional small clusters. Spontaneous 
rhythmic contractions were observed in both single cells and clusters of small cells in BM
+TGF-β1 medium.
Analysis of mRNA expression of cardiac markers
The expression of Nkx2.5 was greater in all media at 4 days of culture as compared with 9 
days, and greater in SM− cells compared with SM+ cells (Fig. 4). In SM− cells, the 
expression of Nkx2.5 was greatest in cells cultured in BM+TGF–β1, and to a lesser extent in 
BM alone and BM+bFGF (Fig. 4). The expression of GATA-4 followed a similar pattern 
except that the greatest expression was in SM− cells cultured in BM+bFGF, followed by 
BM+TGF-β1, and BM alone (Fig. 4). Compared with SM+ cells, Myl2 expression was 
uniformly greater in SM− cells, particularly in presence of bFGF and TGF-β1. Importantly, 
Myl2 expression was greater after 9 days compared with levels after 4 days of culture. These 
observations are consistent with the paradigm that the expression of transcription factors 
would logically precede the expression of structural proteins during lineage commitment. 
Although SM+ cells expressed low levels of Myl2 (a structural protein) at 4 and 9 days, the 
expression of Nkx2.5 and GATA-4 (transcription factors) was clearly detectable in SM+ cells 
at these time-points (Fig. 4). Cell type-specific differences in the time-course of antigen 
expression may be responsible for the differential expression levels of Myl2 in SM− and SM
+ cells at these earlier time-points.
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Impact of media composition on cardiomyogenic differentiation
Freshly isolated SM+ and SM− cells were allowed to differentiate in five different media 
combinations. After 30 days, cells were immunostained for cardiac-specific transcription 
factors (Nkx2.5 and GATA-4) and cardiac-specific structural proteins (cMyHC and α-
sarcomeric actin). Fig. 3f – i demonstrates cardiomyocytic differentiation of SM− cells 
cultured in medium containing BM+TGF-β1. After 30 days, BM alone, BM+insulin, BM
+oxytocin, BM+bFGF, and BM+TGF-β1 induced cardiac differentiation in 11.1 ± 1.0%, 6.2 
± 0.4%, 7.1 ± 1.0%, 9.7 ± 0.8%, and 13.1 ± 1.5% of SM+ cells, respectively (Fig. 5). In 
cultured SM− cells, BM alone, BM+insulin, BM+oxytocin, BM+bFGF, and BM+TGF-β1 
induced cardiac differentiation in 14.0 ± 1.3%, 9.3 ± 1.0%, 10.1 ± 0.2%, 14.0 ± 1.1% and 
21.6 ± 1.6% cells, respectively (Fig. 5). Addition of insulin or oxytocin to BM significantly 
attenuated cardiac differentiation. BM+TGF-β1 was most effective in inducing 
cardiomyogenic differentiation of SM− cells. Compared with insulin, oxytocin, and bFGF, 
addition of TGF-β1 also resulted in greater cardiac differentiation of SM+ cells. These 
findings are consistent with data from mRNA analysis, which showed that addition of TGF-
β1 enhanced the expression of both cardiac-specific transcription factors and structural 
proteins. In addition, we observed spontaneous rhythmic contractions in SM− cell-derived 
cardiomyocytic cells (supplemental Video 1) confirming their cardiomyocytic nature. 
Overall, compared with SM+ cells, SM− cells exhibited greater predisposition to undergo 
cardiomyocytic differentiation (Fig. 5). The myotube differentiation rate was not determined 
because cells were cultured in cardiomyogenic media, and because these myotubes 
frequently fused to form syntitia, thereby precluding an accurate cell count.
Discussion
In order to improve the outcomes of cell therapy for cardiac repair, it is imperative to 
critically evaluate the ability of the candidate cell to differentiate into cardiac lineages in 
vitro. However, little consensus exists regarding the most effective medium composition for 
inducing cardiac differentiation in vitro. Our results demonstrate that: (1) the addition of 
TGF-β1 to medium containing IGF-1 and dynorphin B significantly enhances 
cardiomyogenic differentiation of adult skeletal muscle-derived primitive cells; (2) the 
addition of insulin or oxytocin reduces cardiac differentiation and promotes adipocytic 
differentiation; and (3) SM− cells exhibit greater predisposition to differentiate into a 
cardiomyocytic phenotype, indicating that this specific cell type is inherently more 
amenable to cardiac differentiation. These results have considerable implications for the 
selection of media for in vitro experiments aimed at identifying the most suitable cell 
population for cardiac repair in vivo.
Members of the TGF-β superfamily play important roles in cardiac development during 
embryogenesis [27, 31] as well as in various cardiac pathologies [24, 34]. TGF-β1 has been 
shown to induce cardiac differentiation in vitro in embryonic explants and stem cells [6, 21] 
as well as in adult bone marrow-derived cells [14]. Our results show that compared with 
other combinations, the BM+TGF-β1 combination is most effective in inducing 
cardiomyocytic differentiation of SM− cells in vitro, an effect that was verified by 
morphological examination as well as expression of cardiac-specific transcription factors 
Abdel-Latif et al. Page 7
Basic Res Cardiol. Author manuscript; available in PMC 2014 December 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
and structural proteins at the mRNA and protein levels. TGF-β1 enhanced the expression of 
Nkx2.5 and GATA-4 at 4 days of culture, which was followed by increased expression of 
structural proteins (Myl2 at day 9, and cMyHC and α-sarcomeric actin at later stages). 
Following TGF-β1 receptor binding, the receptor-regulated Smads (R-Smads: Smad2 and 
Smad3) are phosphorylated and form a complex with the common-mediator Smad (Co-
Smad: Smad4) that migrates to the nucleus and binds to specific DNA sequences leading to 
transcriptional activation [31]. Importantly, the regulatory region of the Nkx2.5 gene, an 
early [17] and essential [19] transcription factor for cardiomyogenesis, contains several 
Smad [16] as well as GATA [7] binding sites. Notwithstanding the complex and poorly 
understood interaction between Nkx2.5, GATA-4, and other factors during cardiac 
development, it is plausible that TGF-β1-induced cardiac differentiation is triggered via 
Smad activation of Nkx2.5 and GATA-4, which is followed by the expression of cardiac 
structural proteins.
In a recent study by Li et al. [15], TGF-β1 induced differentiation of bone marrow-derived 
CD117+ cells into immature cardiomyocytes in vitro. Importantly, in a previous study [14], 
transplantation of TGF-β1-primed CD117+ cells into infarcted hearts resulted in myocyte 
regeneration and improvement in LV function. In our study, while a rigorous assessment of 
the cardiomyocyte phenotype via a combinatorial approach (morphology, transcription 
factor, structural protein, spontaneous contraction) enabled an accurate assessment of the 
comparative efficacy of different growth factors in cardiac differentiation induction, whether 
these cardiomyocytic cells achieved the status of mature cardiomyocytes in vitro remained 
unclear. Therefore, to address this issue of maturity from a translational standpoint, future 
studies will be necessary to investigate whether TGF-β1-pre-differentiated SM− cells can 
improve LV structure and function in vivo following transplantation into the infarcted heart.
bFGF (FGF-2) also induced expression of Nkx2.5 and GATA-4; however, 
immunocytochemical quantitation revealed significantly less cardiac differentiation. 
Although bFGF is expressed in the developing heart [28], its role on cardiac specification 
vs. proliferation is unclear [21, 29]. In the study by Hidai et al. [10], FGF-2 suppressed the 
expression of retinoic acid-induced GATA-4 expression, and promoted skeletal muscle 
differentiation in embryonal P19 cells. Interestingly, inhibition of FGFR-1, which serves as 
a receptor for both FGF-1 and FGF-2, was able to block the expression of GATA-4 without 
affecting α-MyHC expression. In the study by Barron et al. [4], transient exposure to FGF-2 
with continuous BMP-2 presence was able to induce a contractile phenotype in non-
precardiac mesoderm. However, longer exposure to FGF-2 was necessary to achieve Nkx2.5 
induction. Our results are consistent with this dichotomy between the induction of cardiac 
transcription factors vs. structural proteins by bFGF, and its role in skeletal myogenesis. 
Further studies will be necessary to determine the signaling machinery activated by bFGF in 
adult primitive cells.
IGF-1 receptor is expressed in the developing heart [5] and IGF-1 has been shown to induce 
cardiac differentiation of transplanted embryonic stem cells [13]. Similarly, the P19 
embryonal cells express prodynorphin, and dynorphin B can induce cardiac differentiation 
in these cells [32]. In our study, although BM (containing IGF-1 and dynorphin B) alone 
upregulated the expression of Nkx2.5 and GATA-4 in SM− cells, cardiomyocytic 
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differentiation was considerably less than that achieved with the addition of TGF-β1. These 
differences from previous reports could be accounted for by the differences in substrates, 
embryonic cells vs. adult primitive cells.
The addition of insulin to BM negatively impacted the expression of cardiac markers. In 
addition, insulin induced marked adipocytic differentiation. In previous studies, insulin has 
been shown to induce contractility in embryonic explants [29] and promote cardiac 
differentiation in embryonic neural precursors [3]. Similar observations have been made in 
adult bone marrow-derived mesenchymal stem cells [26]. It is plausible that adding insulin 
to a medium containing IGF-1 and dynorphin B negatively impacted cardiac differentiation. 
Similarly, the addition of oxytocin also reduced cardiac differentiation compared with BM 
alone and promoted an adipocytic phenotype. Oxytocin is expressed in the developing heart 
[11], and the evidence supporting a role of oxytocin in cardiac differentiation comes 
primarily from studies that used the embryonal P19 cells [8, 22]. Interestingly, amongst 
adult cells, the cardiomyogenic properties of oxytocin has been documented in Sca-1+ 
cardiac progenitors [20]. However, in our study, the effects of oxytocin in Sca-1+ (SM+) 
and Sca-1-(SM−) cells were similar. Thus, the role of oxytocin in cardiac differentiation of 
non-cardiac adult primitive cells remains to be established.
The current results also expand our previous observations regarding the impact of Sca-1 
expression on cardiac differentiation of CD45-/c-kit-/Thy-1 + adult skeletal muscle-derived 
cells [35]. Compared with SM− cells, SM+ cells consistently exhibited lower levels of 
cardiac-specific gene and protein expression in response to the various growth factors used, 
indicating that the negative influence of Sca-1+ expression on cardiac differentiation of 
skeletal muscle-derived CD45-/c-kit-/Thy-1+ primitive cells [35] is independent of the 
culture medium. The greater cardiomyocytic differentiation of SM− cells vs. SM+ cells with 
the same growth factors implies cell type-specific differences. Therefore, these results also 
underscore the importance of carefully selecting the candidate cell for cardiac repair.
Our study has several limitations. First, we did not demonstrate calcium transients in 
differentiated cells. Instead, we documented spontaneous rhythmic contractions in 
cardiomyocytic cells in culture (supplemental Video 1). Second, the cardiomyogenic effects 
of insulin and oxytocin might have been influenced by the presence of IGF-1 and dynorphin 
B in the BM. However, both IGF-1 and dynorphin B are known to induce cardiomyogenesis 
[2, 32], and their presence was therefore more likely to synergistically augment the 
cardiomyogenic effects in all arms. Since the composition of BM was constant in all groups, 
our comparison remains valid. Finally, we did not fully assess whether these SM− cell-
derived cardiomyocytes in vitro attained features consistent with mature adult 
cardiomyocytes, a question that may perhaps be addressed better in a more conducive milieu 
in vivo following transplantation into the infarcted heart.
In conclusion, our results indicate that TGF-β1 enhances cardiomyogenic differentiation of 
skeletal muscle-derived adult primitive cells. This influence was achieved via the 
upregulation of Nkx2.5 and GATA-4 expression. These results may have considerable 
implications for the formulation of optimal medium for the induction of cardiac 
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differentiation in vitro, and selecting the candidate cell population for therapeutic cardiac 
repair in vivo.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Representative dot-plots show the expression (in percentage) of Sca-1 (FITC), CD45 (APC), 
c-kit (APC), and Thy-1.2 (PE) in skeletal muscle-derived cells. Blue lines indicate regions 
included into the sorting logic. From region 1 (R1), CD45-/c-kit- cells positive for Thy-1.2 
are identified in region 5 (R5). Based on Sca-1 expression, cells from R5 are divided into 
Sca-1 +/CD45-/c-kit-/Thy-1 + (SM+) cells in region 7 (R7) and Sca-1-/CD45-/c-kit-/Thy-1+ 
(SM−) cells in region 6 (R6). The percentages in R6 and R7 relate to the total number of 
cells in R1. FSC forward scatter characteristics, SSC side scatter characteristics
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Fig. 2. 
Representative light microscopic images of SM+ cells after 30 days of differentiation 
demonstrating the effects of culture media composition on cellular morphology. Panels a–c 
show the heterogeneous (epithelial, endothelial, adipose, and others) morphology of SM+ 
cells cultured in basic medium (BM) containing IGF-1 and dynorphin B (a), and BM 
supplemented with insulin (b), or oxytocin (c). Exposure of SM+ cells to insulin or oxytocin 
increased differentiation into an adipose phenotype. Supplementation of BM with bFGF (d) 
or TGF-β1 (e) resulted in enhanced myotube formation from SM+ cells. Morphological 
observations were confirmed via immunostaining (f–j). Panel f shows differentiation of SM
+ cells cultured in BM supplemented with insulin into epithelial cells positive for the 
epithelial cytoskeletal marker cytokeratin 17 (red). Panels g–j show representative images of 
SM+ cells stained for the cardiac-specific marker cardiac myosin heavy chain (i,j red), and 
skeletal muscle-specific transcription factor myogenin (h–j, green). Nuclei are stained with 
DAPI (f,g,i,j, blue). Myogenin expression was localized to nuclei (H,l, exemplified by 
arrowheads). Nuclei expressing myogenin (h–j, exemplified by arrowheads) belonged to 
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cells negative for cardiac marker in red fluorescence (h,j) and exhibited morphology 
characteristic of myotubes (j). Scale bar = 40 µm (f) or 20 µm (g–j)
Abdel-Latif et al. Page 15
Basic Res Cardiol. Author manuscript; available in PMC 2014 December 18.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3. 
Representative light microscopic images of SM− cells after 30 days of differentiation 
demonstrating the effects of culture media composition on cellular morphology. Panels a–c 
show the predominant epithelial morphology of SM-cells cultured in basic medium (BM) 
containing IGF-1 and dynorphin B (a), and BM supplemented with insulin (b), or oxytocin 
(c). Scattered cells with adipose morphology were noted throughout the culture plates. 
Panels d and e show the increased frequency of spindle-shaped cells when SM− cells were 
exposed to BM supplemented with bFGF (d) or TGF-β1 (e). Cardiomyogenic differentiation 
was verified via immunostaining. Panels f–i show representative confocal microscopic 
images of SM− cells after 30 days of differentiation in BM supplemented with TGF-β1. 
Mononucleate spindle-shaped cells are identified in the transmission image (f). Cardiac 
differentiation is evidenced by positivity for cardiac-specific transcription factor (Nkx2.5h–i, 
green) and structural protein (cardiac myosin heavy chain, g–i, red). Panels h–i identify 
cells positive for both cardiac-specific transcription factor (in green) and structural protein 
(in red) resulting in yellow fluorescence. Nuclei are stained with DAPI (f,g,i, blue). Scale 
bar = 20 µm
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Fig. 4. 
Quantitative assessment of mRNA expression by qRT-PCR of cardiac-specific markers in 
SM+ and SM− cells after 4 and 9 days of culture in 5 different media. mRNA level is 
expressed as -fold change compared with freshly isolated unfractionated skeletal muscle-
derived cells. Three independent experiments were performed. Data are mean ± SEM
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Fig. 5. 
Percentage of cells positive for cardiac-specific markers (Y axis), demonstrating the effects 
of different media (X axis) on cardiomyogenic differentiation of SM+ and SM− cells. Cells 
positive for cardiac transcription factors (cTFs) and/or structural proteins (cSPs) were 
counted and expressed as a percentage of total cells. The percentage of cells positive for 
cTFs is represented by solid bars, cSPs by white bars, and cells positive for both by cross-
hatched bars. Cardiomyocytic differentiation was noted in both SM+ and SM− populations. 
However, compared with SM+ cells, SM− cells exhibited greater cardiomyogenic potential 
in all media. Supplementation of BM with TGF-β1 resulted in cardiomyocytic 
differentiation in the greatest fraction of cells in both groups
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